publicli
fund
repositori
covid
databas
right
unrestrict
research
reus
analys
form
mean
acknowledg
origin
sourc
permiss
grant
free
elsevi
long
resourc
centr
remain
activ
evid
level
random
control
trial
rct
metaanalys
welldesign
systemat
review
rct
b
casecontrol
cohort
studi
nonrandom
clinic
trial
systemat
review
studi
rct
crosssect
studi
retrospect
studi
certain
uncontrol
studi
c
consensu
statement
expert
guidelin
usual
practic
opinion
c
h
p
e
r
product
cough
acut
bronchiti
acut
bronchiti
common
diagnosi
usual
caus
viral
infect
caus
acut
cough
pneumonia
gastroesophag
reflux
diseas
allergi
consid
best
avail
evid
suggest
antibiot
may
reduc
symptom
ill
durat
slightli
cost
side
effect
make
benefitharm
trade
tenuou
best
neither
age
smoke
statu
link
antibiot
effect
doxycyclin
erythromycin
trimethoprimsulfamethoxazol
test
posit
report
random
control
trial
rct
henc
antibiot
consid
littl
rctbase
evid
effect
antituss
treatment
howev
limit
use
may
support
especi
cough
interf
sleep
nonsteroid
antiinflammatori
drug
effect
pain
signific
toxic
risk
rais
need
caution
overthecount
cold
formula
contain
decongest
andor
antihistamin
appropri
treatment
acut
bronchiti
may
help
nasal
congest
drainag
present
mucolyt
expector
adequ
assess
acut
bronchiti
evid
common
cold
chronic
bronchiti
suggest
possibl
effect
jane
doe
woman
present
clinic
product
cough
day
durat
jane
first
felt
ill
week
ago
first
octob
rememb
feel
scratchi
throat
progress
sore
throat
gener
malais
cough
cough
bothersom
day
night
kept
awak
awaken
sleep
past
week
cough
phlegm
first
clear
white
green
brown
blood
felt
altern
slightli
feverish
chilli
first
day
ill
deni
high
temperatur
felt
feverish
past
sever
day
deni
nasal
symptom
chest
pain
short
breath
vomit
may
increas
dyspnea
exert
especi
begin
ill
deni
sensat
maxillari
pain
postnas
drip
sore
throat
resolv
acut
ill
caus
reduc
smoke
cigarett
day
note
realli
quit
stuff
use
overthecount
combin
cold
formula
believ
help
manag
cough
although
make
bit
groggi
known
jane
sinc
first
came
year
ago
chest
pain
previous
neglect
health
care
mani
year
origin
chest
pain
burn
qualiti
bother
felt
stress
diagnos
empir
reflux
esophag
respond
antacid
heartburn
well
control
lifestyl
modif
ranitidin
zantac
mg
twice
daili
routin
health
screen
reveal
tobacco
use
one
pack
per
day
year
hyperlipidemia
well
control
statin
also
take
daili
aspirin
heart
attack
stroke
prevent
blood
pressur
rang
normal
borderlin
random
blood
glucos
screen
normal
two
urinari
tract
infect
sinc
come
resolv
fluid
short
cours
antibiot
motiv
counsel
reduc
cigarett
consumpt
less
half
pack
per
day
improv
diet
walk
brisk
mile
sever
day
per
week
mammogram
pap
smear
screen
sigmoidoscopi
neg
jane
receiv
recommend
childhood
immun
declin
influenza
vaccin
rememb
receiv
antibiot
acut
cough
ill
sever
year
meet
jane
father
die
heart
attack
age
smoker
jane
mother
aliv
well
diagnos
type
diabet
hypertens
jane
grandpar
die
unknown
caus
brother
two
sister
unawar
major
health
issu
jane
marri
three
adult
children
work
offic
manag
attribut
daili
work
stress
relationship
stress
primari
obstacl
smoke
cessat
husband
nag
quit
smoke
deni
physic
sexual
abus
addit
acut
symptom
mention
jane
occasion
mild
heartburn
gener
well
control
antacid
ranitidin
deni
chest
pain
pressur
exercis
also
deni
weight
loss
feel
gener
health
energi
qualiti
life
improv
slightli
past
year
awar
signific
occup
environment
exposur
live
citi
occasion
ozon
alert
jane
feet
inch
pound
bodi
mass
index
blood
pressur
today
mm
hg
heart
rate
beat
per
minut
temperatur
ear
thermomet
respiratori
rate
breath
per
minut
mucou
membran
ocular
nasal
oral
moist
without
abnorm
sign
tympan
membran
clear
normal
light
reflex
sign
middl
ear
fluid
posterior
pharynx
somewhat
erythemat
without
exud
swell
sign
postnas
drainag
tender
maxillari
percuss
two
small
smooth
mobil
nontend
lymph
node
palpabl
anterior
chain
left
side
neck
posterior
auscult
lung
reveal
neither
rale
rhonchi
inspiratori
effort
good
full
symmetr
chest
wall
expans
heart
sound
normal
consid
chest
radiograph
peak
flow
complet
blood
count
creactiv
protein
andor
test
streptococc
pharyng
pertussi
decid
order
test
although
seen
jane
specif
constel
symptom
presumpt
diagnos
acut
bronchiti
like
caus
recent
perhap
ongo
upper
airway
viral
infect
midairway
inflammatori
sequela
chronic
exposur
tobacco
smoke
possibl
airborn
pollut
like
underli
contributori
factor
list
possibl
caus
acut
cough
ill
includ
asthma
bronchiectasi
cancer
chemic
bronchiti
chronic
obstruct
pulmonari
diseas
drug
eg
angiotensinconvert
enzym
inhibitor
eosinophil
bronchiti
gastroesophag
reflux
diseas
interstiti
lung
diseas
pneumonia
sinus
infecti
viral
respiratori
pathogen
includ
adenoviru
coronaviru
enteroviru
influenza
parainfluenza
respiratori
syncyti
viru
rhinoviru
class
viru
mani
subtyp
henc
sever
hundr
specif
viral
strain
lead
upper
respiratori
infect
cough
know
influenza
respiratori
syncyti
viru
confin
month
novemb
april
local
thu
today
differenti
diagnosi
last
year
state
experienc
epidem
pertussi
eventu
control
aggress
testandtreat
strategi
year
state
public
health
depart
report
rare
case
sinus
exclud
lack
fever
face
pain
maxillari
tender
purul
discharg
nasal
passageway
posterior
pharynx
histori
occup
environment
exposur
histori
esophag
reflux
suggest
possibl
contribut
symptom
much
specif
acut
infecti
bronchiti
presum
viral
chapter
product
cough
acut
bronchiti
acut
bronchiti
presum
viral
common
clinic
diagnosi
sensit
specif
support
test
main
diagnost
job
clinician
rule
caus
jane
neither
paroxysm
whoop
cough
known
exposur
risk
factor
therefor
decid
uncomfort
nasopharyng
swab
requir
pertussi
polymeras
chain
reaction
test
normal
vital
sign
lung
sound
lack
chest
pain
pressur
persist
fever
short
breath
decid
pretest
probabl
pneumonia
low
order
chest
radiograph
awar
recent
research
show
creactiv
protein
might
use
absenc
chest
radiograph
almiral
et
al
b
flander
et
al
b
garcia
et
al
b
also
know
nonspecif
help
case
note
histori
heartburn
respons
h
blocker
discuss
possibl
esophag
reflux
diseas
may
contribut
jane
symptom
togeth
decid
schedul
upper
endoscopi
sometim
next
month
two
care
consider
detail
discuss
risk
benefit
suggest
conserv
treatment
drink
lot
fluid
rest
cough
medicin
jane
tri
overthecount
dextromethorphanguaifenesin
combin
cough
syrup
unsuccess
especi
cough
keep
awak
night
fill
prescript
codeineguaifenesin
cough
syrup
avoid
cold
formula
antihistamin
decongest
neither
allerg
symptom
nasal
congest
agent
side
effect
risk
well
expens
specif
ask
jane
whether
want
expect
antibiot
prescript
say
would
take
medicin
think
would
help
ask
opinion
discuss
fact
antibiot
may
slightli
better
placebo
reliev
symptom
sever
durat
acut
bronchiti
howev
also
note
risk
side
effect
touch
societ
problem
antibiot
resist
offer
delay
fill
antibiot
prescript
jane
declin
also
provid
reassur
symptom
go
away
give
specif
sign
would
requir
return
visit
hemoptysi
short
breath
difficulti
breath
chest
pain
pressur
persist
fever
cough
last
week
gentli
discuss
associ
smoke
bronchiti
mention
million
american
kick
habit
believ
see
jane
smoke
cessat
counsel
followup
upper
endoscopi
perform
gastroenterologist
colleagu
show
small
hiatal
hernia
specif
lesion
sign
esophag
inflamm
although
smoke
cessat
initi
unsuccess
sever
attempt
year
jane
eventu
kick
habit
meantim
two
occurr
acut
bronchiti
treat
home
fluid
rest
overthecount
cough
suppress
acut
bronchiti
common
result
upper
respiratori
infect
although
bacteri
chemic
caus
known
vast
major
case
acut
bronchiti
stem
viral
agent
known
effect
treatment
acut
bronchiti
whether
cough
product
color
phlegm
predict
etiolog
agent
viru
vs
bacteria
respons
therapi
systemat
review
rct
antibiot
suggest
small
statist
signific
benefit
antibiot
placebo
term
persist
sever
cough
anonym
smucni
et
al
nine
publish
rct
three
posit
report
statist
signific
benefit
doxycyclin
verheij
et
al
erythromycin
dunlay
et
al
frank
gleiner
fail
find
substanti
benefit
primari
outcom
trend
toward
benefit
secondari
outcom
reach
statist
signific
note
number
unpublish
rct
unknown
howev
suspect
sever
neg
trial
conduct
drug
compani
remain
unpublish
posit
trial
like
publish
neg
trial
intern
bias
tend
favor
treatment
placebo
actual
benefit
may
less
rct
specif
address
question
whether
antibiot
use
tobacco
smoker
acut
bronchiti
howev
linder
sim
review
nine
trial
chapter
product
cough
acut
bronchiti
note
particip
look
specif
smoker
includ
statist
signific
differ
smoker
nonsmok
howev
trend
actual
suggest
antibiot
less
effect
smoker
nonsmok
secondari
analysi
data
dredg
henc
conclus
tent
certainli
support
widespread
practic
justifi
antibiot
prescript
smoke
statu
although
may
reason
prescrib
antibiot
patient
acut
bronchiti
eg
earli
pneumonia
suspect
underli
chronic
lung
diseas
expert
recommend
practic
anonym
gonzal
et
al
c
societ
harm
antibiot
resist
individu
advers
effect
may
outweigh
potenti
benefit
side
effect
antibiot
nausea
diarrhea
vagin
candidiasi
allerg
reaction
occur
frequent
antibiot
use
antibiot
acut
bronchiti
number
need
treat
walter
number
need
harm
similar
rang
anonym
cantrel
et
al
b
walter
stone
et
al
b
unfortun
situat
due
patient
demand
physician
belief
prescrib
habit
educ
form
pamphlet
physician
advic
significantli
reduc
desir
antibiot
macfarlan
et
al
evid
suggest
write
delay
prescript
may
reduc
antibiot
use
arrol
et
al
unfortun
littl
reliabl
evid
regard
effect
cough
treatment
systemat
review
rct
conclud
neither
good
evid
good
evid
effect
antituss
anonym
schroeder
fahey
smith
feldman
howev
definit
possibl
specif
effect
parvez
evid
suggest
placebo
effect
cough
treatment
substanti
eccl
lee
et
al
b
use
overthecount
dextromethorphancontain
formul
andor
limit
use
prescript
codein
hydrocodon
may
reason
although
benzonat
tessalon
approv
prescript
cough
medicin
virtual
evid
effect
furthermor
number
qualiti
rct
beta
agonist
eg
albuterol
inhal
use
set
acut
bronchiti
limit
although
evid
support
use
hueston
weight
evid
current
suggest
beta
agonist
help
set
anonym
smucni
et
al
expector
mucolyt
adequ
assess
set
acut
bronchiti
howev
evid
trial
common
cold
set
chronic
lung
diseas
suggest
possibl
benefit
littl
harm
anonym
schroeder
fahey
smith
feldman
neither
antihistamin
decongest
shown
help
bronchiti
carri
risk
antihistamin
caus
drowsi
may
lead
motor
vehicl
accid
decongest
contraind
set
hypertens
heart
diseas
children
evid
benefit
overthecount
medicin
cold
bronchiti
reason
evid
potenti
harm
anonym
gunn
et
al
schroeder
fahey
nonsteroid
antiinflammatori
drug
may
help
pain
present
howev
widespread
use
nonsteroid
antiinflammatori
drug
associ
major
morbid
mortal
american
die
year
mostli
gastrointestin
bleed
also
congest
heart
failur
renal
failur
fri
b
heerdink
et
al
b
page
henri
wolf
et
al
b
although
effect
nonsteroid
antiinflammatori
drug
appear
similar
risk
vari
ibuprofen
among
safest
acetaminophen
nonsteroid
antiinflammatori
drug
even
safer
broad
bodi
robust
evid
tobacco
smoke
cessat
facilit
varieti
physicianassist
modal
although
specif
evid
link
acut
ill
readi
quit
make
good
sens
occas
episod
acut
bronchiti
might
provid
opportun
incent
support
activ
attempt
tobacco
cessat
least
plant
seed
fact
jane
father
smoke
die
heart
attack
age
might
also
diplomat
use
motiv
tool
acut
bronchiti
common
diagnosi
patient
present
prolong
acut
cough
specif
method
diagnos
bronchapt
product
cough
acut
bronchiti
chiti
distinguish
bronchiti
upper
respiratori
infect
cough
first
job
clinician
rule
caus
pneumonia
asthma
bacteri
sinus
gastroesophag
reflux
diseas
diagnosi
acut
infecti
bronchiti
reach
clinician
task
turn
support
patient
term
reassur
select
therapi
case
antibiot
avoid
unless
better
evid
emerg
use
overthecount
prescript
antituss
cautious
support
adult
decongest
avoid
especi
hypertens
heart
diseas
present
betaagonist
inhal
may
help
wheez
histori
asthma
support
home
treatment
fluid
rest
avoid
stressor
make
good
sens
larg
unsupport
evid
unless
symptom
dramat
worsen
patient
acut
bronchiti
need
return
visit
